Cargando…
Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide
The IL-13Rα2 cell surface receptor is highly expressed in tumours such as prostate cancer. In this report, we evaluated the hypothesis that prostate cancer cells with enhanced IL-13Rα2 expression are a suitable target for the hybrid lytic peptide (Pep-1-Phor21) peptide, which is generated by fusing...
Autores principales: | Jannoo, Riaz, Xia, Zhidao, Row, Paula E., Kanamarlapudi, Venkateswarlu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953383/ https://www.ncbi.nlm.nih.gov/pubmed/36830725 http://dx.doi.org/10.3390/biom13020356 |
Ejemplares similares
-
Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide
por: Jannoo, Riaz, et al.
Publicado: (2023) -
Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
por: Wood, Nancy, et al.
Publicado: (2003) -
Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex
por: Tollenaere, Maxim A.X., et al.
Publicado: (2023) -
Role of hypoxia inducible factor 1α in cobalt nanoparticle induced cytotoxicity of human THP-1 macrophages
por: Francis, Wendy Rachel, et al.
Publicado: (2021) -
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers
por: Liang, Ruijia, et al.
Publicado: (2022)